Episode Details
Back to Episodes
Pharmaceutical Executive Daily: TrumpRx's Implication on DTC Commercialization
Published 6 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover the emergence of TrumpRx and its implications for direct-to-consumer drug commercialization, new funding momentum across rare disease R&D, and Eli Lilly’s definitive agreement to acquire Aderum Biotechnologies.